The company announced that it intends to offer, subject to market conditions and other factors, $500,000,000 aggregate principal amount of convertible senior notes due 2029 (the "notes") in a private
Lowe's Companies shares rose after reporting better-than-expected Q1 FY24 earnings. Sales declined 4.4% year-on-year to $21.364 billion, surpassing estimates. EPS of $3.06 beat the expected $2.94. Despite a drop in DIY discretionary spending, positive sales in Pro and online sectors helped. Lowe's still projects FY24 revenue of $84-$85 billion and EPS of $12.00-$12.30.
AstraZeneca aims to boost its revenue from $45.8 billion in 2023 to $80 billion by 2030. Key growth drivers include expanding oncology, biopharmaceuticals, rare disease portfolios, and launching 20 new medicines.
The open interest in Ethereum (CRYPTO: ETH) futures has reached an all-time high of $15.1 billion, reflecting a surge in investor interest. This spike is attributed to the growing optimism surrounding the potential approval of spot exchange-traded funds in the U.S.